Program | Excipients Innovations 2015

Program


New York

2015-03-31 09:00 AM

clock

Overview of the specialty excipients market for OSDF pharmaceuticals

  • Consumption patterns in the 4 key global markets (Europe, US, India, China)
  • Key market drivers and restraints and their impact on consumption
  • Competitive landscape in the Specialty excipients market globally and local specificities
  • Market outlook: where will be the opportunities in the next 5 years
  • Nikola Matic
  • Nikola Matic
  • Industry Manager, Chemicals & Materials
  • Kline & Company
  • LinkedIn Nikola Matic

New York

2015-03-31 09:45 AM

clock

Quality Risk Management for Excipients

Quality and compliance have always been core values at Capsugel – and the keys to the company’s trusted place in the industry. Capsugel strives to maintain internal quality and compliance policies that stay a step ahead of current regulations. As a result of its efforts, in 2014 Capsugel became the first hard capsule manufacturer to receive the distinctive EXCiPACT™ excipient GMP certification, which provides third-party validation that Capsugel maintains excipient GMPs and complies with current EU regulations. This webinar covers the regulatory background regarding the EU Directive on Falsified Medicines, the process and scope of the EXCiPACT™ excipient GMP certification and the related benefits to companies marketing pharmaceutical products in the EU.


New York

2015-03-31 10:30 AM

clock

Dow AFFINISOL™ polymers for Solubility Enhancement

Dow has developed the AFFINISOL™ line of excipients to enable solubility enhancement.

Hypromellose acetate succinate (HPMCAS) has proven effective at producing stable amorphous solid dispersions for poorly soluble APIs. We will highlight:
• Utility of commercial grades of AFFINISOL™ HPMCAS
• AFFINISOL™ HPMCAS Quality by Design sample sets in the formulation of solid dispersions
• Innovative high productivity HPMCAS polymer providing similar product performance while reducing solution viscosity allowing for increased solids loading in the feed solution.

AFFINISOL™ HPMC HME provides a broader extrusion operating window, improved melt flow and resistance to color change at elevated temperatures. The study shows:
• Processing versatility of this polymer in HME
• Polymer utility in solubility enhancement


New York

2015-03-31 11:15 AM

clock

Excipient innovation: Formulating the drugs of tomorrow

The concept of a dosage form has been around for a long time. 2,400 years ago, Sumerian doctors in Nippur, an ancient city located in modern day Iraq, detailed how to make medical treatments in recipes written on clay tablets.
In the millennia since, dosage forms have continued to develop with drugmakers like Merck KGaA, Roche and Pfizer – which have their origins in apothecaries and dye makers founded in the 19th century – using excipients to try and find ways of delivering APIs to patients more effectively.
Such efforts are accelerating as the drug industry move into the era of personalised medicine and complex drugs.
In this webinar, leading academics will give us a potted history of drug formulation and share some of the cutting edge developments in the field of excipients that will shape the pills, potions, powders and capsules of tomorrow.

  • Nikola Matic
  • Nikola Matic
  • Industry Manager, Chemicals & Materials
  • Kline & Company
  • LinkedIn Nikola Matic